Signaling Pathways - Liver X receptors (LXRs) - Ferroptosis - eIF4E/eIF3G interaction - Insulin and Insulin-like Receptors
清除全部
- A8714 SR-9243Target: Liver X receptors (LXRs)Summary: LXR反相激动剂
- B3696 4EGI-12 CitationTarget: eIF4E/eIF3G interactionSummary: 竞争性的eIF4E/eIF4G相互作用抑制剂。
- B1264 LXR-6232 CitationTarget: Liver X receptors (LXRs)Summary: 肝X受体激动剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A2249 T0901317Target: Liver X receptors (LXRs)Summary: 肝X受体激动剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A3454 GW39651 CitationTarget: Liver X receptors (LXRs)Summary: 高效选择性HLXRα/hLXRβ激动剂
- A4371 Ferrostatin-1 (Fer-1)Target: FerroptosisSummary: Erastin诱导的Ferroptosis抑制剂